Biopharma firms battle for ECM supply edge
South Korea’s pharmaceutical and biotech companies are rapidly entering the fast-growing market for ECM-based skin boosters, intensifying competition in what industry insiders describe as a “battle for raw materials.”Extracellular matrix (ECM) skin boosters, derived from human tissue, have gained popularity in the medical aesthetics sector for their ability..